Farmaci sintomatici specifici e aspecifici per il trattamento acuto dell'attacco emicranico: Nuove opzioni terapeutiche

Translated title of the contribution: Specific and non-specific drugs in the treatment of migraine attacks: New options

G. Nappi, G. Sances, C. Tassorelli, R. Ambrosio, G. Sandrini

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effectiveness of various symptomatic drugs has been documented by controlled clinical trials. A review of the data from the literature has identified a group of substances that proved significantly better than placebo in at least two controlled trials. These drugs include triptans, ergots, non-steroidal anti-inflammatory drugs and anti-emetics. With the exception of ergotamine, which is ineffective or may even worsen nausea, all of them possess both analgesic and anti-emetic effects, provided that they are used according to the proper dosage and administration route. The choice of the appropriate drug, formulation and route of administration is a crucial step in the therapeutic approach of migraine. This choice must be guided by the clinical characteristics of the migraine attack, co-morbid or associated conditions, drug-related factors and patient' preferences.

Original languageItalian
Pages (from-to)69-83
Number of pages15
JournalConfinia Cephalalgica
Volume9
Issue number2
Publication statusPublished - 2000

Fingerprint

Migraine Disorders
Antiemetics
Pharmaceutical Preparations
Ergotamine
Tryptamines
Drug Compounding
Patient Preference
Controlled Clinical Trials
Therapeutics
Nausea
Analgesics
Anti-Inflammatory Agents
Placebos

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Farmaci sintomatici specifici e aspecifici per il trattamento acuto dell'attacco emicranico : Nuove opzioni terapeutiche. / Nappi, G.; Sances, G.; Tassorelli, C.; Ambrosio, R.; Sandrini, G.

In: Confinia Cephalalgica, Vol. 9, No. 2, 2000, p. 69-83.

Research output: Contribution to journalArticle

@article{2ef25aea96b546d28873bccbf433b65b,
title = "Farmaci sintomatici specifici e aspecifici per il trattamento acuto dell'attacco emicranico: Nuove opzioni terapeutiche",
abstract = "The effectiveness of various symptomatic drugs has been documented by controlled clinical trials. A review of the data from the literature has identified a group of substances that proved significantly better than placebo in at least two controlled trials. These drugs include triptans, ergots, non-steroidal anti-inflammatory drugs and anti-emetics. With the exception of ergotamine, which is ineffective or may even worsen nausea, all of them possess both analgesic and anti-emetic effects, provided that they are used according to the proper dosage and administration route. The choice of the appropriate drug, formulation and route of administration is a crucial step in the therapeutic approach of migraine. This choice must be guided by the clinical characteristics of the migraine attack, co-morbid or associated conditions, drug-related factors and patient' preferences.",
keywords = "Analgesics, Antiemetics, Combination products, Ergot-derivatives, Migraine, Triptans",
author = "G. Nappi and G. Sances and C. Tassorelli and R. Ambrosio and G. Sandrini",
year = "2000",
language = "Italian",
volume = "9",
pages = "69--83",
journal = "Confinia Cephalalgica",
issn = "1122-0279",
publisher = "Fondazione CIRNA",
number = "2",

}

TY - JOUR

T1 - Farmaci sintomatici specifici e aspecifici per il trattamento acuto dell'attacco emicranico

T2 - Nuove opzioni terapeutiche

AU - Nappi, G.

AU - Sances, G.

AU - Tassorelli, C.

AU - Ambrosio, R.

AU - Sandrini, G.

PY - 2000

Y1 - 2000

N2 - The effectiveness of various symptomatic drugs has been documented by controlled clinical trials. A review of the data from the literature has identified a group of substances that proved significantly better than placebo in at least two controlled trials. These drugs include triptans, ergots, non-steroidal anti-inflammatory drugs and anti-emetics. With the exception of ergotamine, which is ineffective or may even worsen nausea, all of them possess both analgesic and anti-emetic effects, provided that they are used according to the proper dosage and administration route. The choice of the appropriate drug, formulation and route of administration is a crucial step in the therapeutic approach of migraine. This choice must be guided by the clinical characteristics of the migraine attack, co-morbid or associated conditions, drug-related factors and patient' preferences.

AB - The effectiveness of various symptomatic drugs has been documented by controlled clinical trials. A review of the data from the literature has identified a group of substances that proved significantly better than placebo in at least two controlled trials. These drugs include triptans, ergots, non-steroidal anti-inflammatory drugs and anti-emetics. With the exception of ergotamine, which is ineffective or may even worsen nausea, all of them possess both analgesic and anti-emetic effects, provided that they are used according to the proper dosage and administration route. The choice of the appropriate drug, formulation and route of administration is a crucial step in the therapeutic approach of migraine. This choice must be guided by the clinical characteristics of the migraine attack, co-morbid or associated conditions, drug-related factors and patient' preferences.

KW - Analgesics

KW - Antiemetics

KW - Combination products

KW - Ergot-derivatives

KW - Migraine

KW - Triptans

UR - http://www.scopus.com/inward/record.url?scp=0033829579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033829579&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0033829579

VL - 9

SP - 69

EP - 83

JO - Confinia Cephalalgica

JF - Confinia Cephalalgica

SN - 1122-0279

IS - 2

ER -